Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anastasios Gianakakos currently holds 72,848 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anastasios Gianakakos has been a net seller of MAPP stock. They have purchased $132.5K and sold $17.6M worth of shares.
Anastasios Gianakakos's most recent insider trade was on Feb 15, 2024, when they sold 36,300 shares at $0.00 per share.
Anastasios Gianakakos serves as Executive at MAP Pharmaceuticals, Inc. (MAPP). They have executed 449 insider transactions totaling $17.7M over their tenure at the company.
Anastasios Gianakakos holds the position of Executive at MAP Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Anastasios Gianakakos has shown a selling trading pattern, with $132.5K in total purchases and $17.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anastasios Gianakakos was on May 11, 2020, when they sold $1.9M worth of MYOK shares. This transaction involved 18,581 shares at $101.90 per share.
Anastasios Gianakakos currently owns 72,848 shares of MAP Pharmaceuticals, Inc. (MAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anastasios Gianakakos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anastasios Gianakakos has 449 Form 4 filings on record as an insider at MAP Pharmaceuticals, Inc..
Set alerts for Anastasios Gianakakos and 40,000+ other insiders.